Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$209.01 - $232.56 $13 Million - $14.5 Million
-62,306 Reduced 4.31%
1,384,148 $302 Million
Q4 2023

Feb 07, 2024

SELL
$197.69 - $227.29 $1.69 Million - $1.94 Million
-8,524 Reduced 0.59%
1,446,454 $329 Million
Q3 2023

Nov 09, 2023

SELL
$201.05 - $221.7 $1.04 Million - $1.15 Million
-5,192 Reduced 0.36%
1,454,978 $293 Million
Q2 2023

Aug 09, 2023

SELL
$211.93 - $241.33 $3.46 Million - $3.94 Million
-16,339 Reduced 1.11%
1,460,170 $352 Million
Q1 2023

May 12, 2023

BUY
$213.32 - $257.83 $3.41 Million - $4.12 Million
15,962 Added 1.09%
1,476,509 $339 Million
Q4 2022

Feb 09, 2023

SELL
$203.72 - $248.97 $4.07 Million - $4.97 Million
-19,982 Reduced 1.35%
1,460,547 $344 Million
Q3 2022

Nov 10, 2022

SELL
$204.81 - $262.19 $17.7 Million - $22.6 Million
-86,229 Reduced 5.5%
1,480,529 $303 Million
Q2 2022

Aug 12, 2022

BUY
$213.86 - $277.87 $1.46 Million - $1.9 Million
6,839 Added 0.44%
1,566,758 $367 Million
Q1 2022

May 13, 2022

SELL
$259.82 - $298.18 $4.15 Million - $4.76 Million
-15,959 Reduced 1.01%
1,559,919 $411 Million
Q4 2021

Feb 09, 2022

SELL
$271.6 - $314.21 $4.11 Million - $4.75 Million
-15,126 Reduced 0.95%
1,575,878 $495 Million
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $9.58 Million - $10.7 Million
34,864 Added 2.24%
1,591,004 $448 Million
Q2 2021

Aug 12, 2021

BUY
$251.87 - $278.14 $39.2 Million - $43.3 Million
155,637 Added 11.11%
1,556,140 $429 Million
Q1 2021

May 14, 2021

SELL
$204.88 - $255.03 $1.03 Million - $1.28 Million
-5,012 Reduced 0.36%
1,400,503 $357 Million
Q4 2020

Feb 25, 2021

BUY
$186.91 - $214.42 $263 Million - $301 Million
1,405,515 New
1,405,515 $286 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $22.1B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.